RECRUITING

Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Investigators will test the effectiveness of adaptive strategies on timely adoption of cervical cancer treatment in Botswana using a pragmatic trial design.

Official Title

Thibang Diphatlha: Testing Adaptive Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana

Quick Facts

Study Start:2023-09-01
Study Completion:2027-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05952141

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. are biological females
  2. 2. are aged 18 or older
  3. 3. have pathology-confirmed invasive cervical cancer diagnosis
  4. 4. have pathology results evaluated at National Health Laboratory in Botswana
  5. 5. are citizens of Botswana
  6. 6. have no prior history of invasive cervical cancer
  1. 1. are biological males or otherwise born without a cervix
  2. 2. are below the age of 18 due to the rarity of cervical cancer in this population
  3. 3. do not meet study inclusion criteria

Contacts and Locations

Study Contact

Katharine Rendle, PhD,MSW,MPH
CONTACT
215-349- 5442
katharine.rendle@pennmedicine.upenn.edu
Hannah Toneff, MSW, MA
CONTACT
267-882-3186
hannah.toneff@pennmedicine.upenn.edu

Principal Investigator

Katharine Rendle, PhD,MSW,MPH
PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Surbhi Grover, MD, MPH
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: Abramson Cancer Center at Penn Medicine

  • Katharine Rendle, PhD,MSW,MPH, PRINCIPAL_INVESTIGATOR, University of Pennsylvania
  • Surbhi Grover, MD, MPH, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-01
Study Completion Date2027-08-31

Study Record Updates

Study Start Date2023-09-01
Study Completion Date2027-08-31

Terms related to this study

Keywords Provided by Researchers

  • Screening
  • Botswana
  • Treatment
  • Patient

Additional Relevant MeSH Terms

  • Cervical Cancer